Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems. The expression systems are developed by cloning in the specific antibody DNA sequences from immunoreactive rabbits. Then, individual clones are screened to select the best candidates for production. The advantages of using recombinant rabbit monoclonal antibodies include: better specificity and sensitivity, lot-to-lot consistency, animal origin-free formulations, and broader immunoreactivity to diverse targets due to larger rabbit immune repertoire.
Keratin 8 belongs to the type B (basic) subfamily of high molecular weight keratins and exists in combination with cytokeratin 18 (type A; acidic subfamily of low molecular weight keratins).
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Protein Aliases: adriamycin resistance-associated; Beta-PAK; Cell proliferation-inducing gene 46 protein; CK-18; CK-8; cytokeratin 18; cytokeratin 8; Cytokeratin endo A; Cytokeratin endo B; Cytokeratin-18; Cytokeratin-8; Endo B; K18; K8; Keratin; keratin 18, type I; keratin 8, type II; keratin complex 1, acidic, gene 18; keratin complex 2, basic, gene 8; Keratin D; Keratin, type I cytoskeletal 18; Keratin, type II cytoskeletal 8; Keratin-18; Keratin-8; Oligophrenin-3; p21 (CDKN1A)-activated kinase 3; p21 protein (Cdc42/Rac)-activated kinase 3; p21-activated kinase 3; PAK-3; Serine/threonine-protein kinase PAK 3; type I cytoskeletal 18; type II cytoskeletal 8; Type-II keratin Kb8
Gene Aliases: AA960620; AL022697; ARA; AU019895; beta-PAK; bPAK; CARD2; CK-18; CK-8; CK18; CK8; CYK18; CYK8; EndoA; K18; K2C8; K8; Kerd; KO; Krt-2.8; Krt1-18; KRT18; Krt2-8; KRT8; MRX30; MRX47; OPHN3; PAK-3; PAK3; PAK3beta; PIG46